Dr. Canter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1514 Jefferson Hwy
New Orleans, LA 70121Phone+1 504-842-4083Fax+1 504-842-0248- Is this information wrong?
Education & Training
- Fox Chase Cancer CenterFellowship, Urologic Surgical Oncology, 2009 - 2011
- University of Pennsylvania Health SystemResidency, Urology, 2005 - 2009
- George Washington University School of Medicine and Health SciencesClass of 2004
Certifications & Licensure
- GA State Medical License 2010 - 2025
- LA State Medical License 2015 - 2020
- FL State Medical License 2014 - 2016
- PA State Medical License 2004 - 2016
- American Board of Urology Urology
Clinical Trials
- PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors Start of enrollment: 2012 Sep 01
- Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform Start of enrollment: 2019 Dec 01
Publications & Presentations
PubMed
- The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center.Daniel J Canter, Caroline Branch, Jason Shelnutt, Aimee J Foreman, Amy M Lehman, Varun Sama, David K Edwards, John Abran> ;Advances in Radiation Oncology. 2023 Mar 27
- 5 citationsAntiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of...Anirban P Mitra, Vikram M Narayan, Sharada Mokkapati, Tanner Miest, Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, Neal D Shore, Leonard G Gomella, Ashis...> ;European Urology. 2022 Mar 1
- 6 citationsPersonalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy.Jonathan D. Tward, Thorsten Schlomm, Stephen Bardot, Daniel J. Canter, Troy Scroggins, Stephen J. Freedland, Lauren Lenz, Darl D. Flake, Todd Cohen, Michael K. Brawer,...> ;Clinical Genitourinary Cancer. 2021 Jan 19
- Join now to see all
Press Mentions
- Georgia Urologist Has Urgent Message for Men: Don’t Delay Screenings for Prostate CancerSeptember 14th, 2021
- Myriad Presents Two New Studies at the Western Section of the American Urological AssociationNovember 2nd, 2018
Hospital Affiliations
- Emory Decatur HospitalDecatur, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: